Literature DB >> 1355952

Simulated assembly line performance following ingestion of cetirizine or hydroxyzine.

J K Walsh1, M J Muehlbach, P K Schweitzer.   

Abstract

Twelve healthy subjects participated in three daytime work periods, in a double-blind repeated measures Latin square design. Subjects received cetirizine (10 mg), hydroxyzine (25 mg), or placebo at 0800. Performance was measured each day during eight 50-minute test periods on a simulated assembly line task between 0830 and 1700. Before entry into the study, subjects were trained to a minimum 80% correction rate on the performance task. Performance decrements were consistently associated with hydroxyzine but not with cetirizine. Subjects made fewer correct responses with hydroxyzine compared with both cetirizine and placebo. Subjectively, participants reported feeling sleepier and performing worse during the hydroxyzine condition than following placebo. Cetirizine, however, did not differ from the other two conditions on self-assessments of alertness or performance. These findings support the hypothesis that objective measures of human functioning are more specific than are subjective measures.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355952

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  8 in total

Review 1.  Sedation, cognition, and antihistamines.

Authors:  Julie C Qidwai; Ginger S Watson; John M Weiler
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

Review 2.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Selecting the optimal oral antihistamine for patients with allergic rhinitis.

Authors:  Jeffrey M Lehman; Michael S Blaiss
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 4.  Comparative tolerability of second generation antihistamines.

Authors:  F Horak; U P Stübner
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

5.  Cetirizine: a review of its use in allergic disorders.

Authors:  Monique P Curran; Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 7.  Central nervous system effects of the second-generation antihistamines marketed in Japan--review of inter-drug differences using the proportional impairment ratio (PIR)-.

Authors:  Tatsuya Isomura; Takeshi Kono; Ian Hindmarch; Norimasa Kikuchi; Aya Murakami; Kyoko Inuzuka; Seiji Kawana
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

Review 8.  Diagnosis and management of rhinitis.

Authors:  D Weldon
Journal:  Prim Care       Date:  1998-12       Impact factor: 2.907

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.